Product Information
DOXEPIN 50 MG CAPSULE is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1463 per EA under NDC 00378425010. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
50 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378425010
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA070791On Market Since
5/13/1986
Pharmacological Classes
Price Statistics
The NADAC for DOXEPIN 50 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 41.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1463 per EA |
|---|---|
| All-time high | $0.9118 (Jan 11, 2017) |
| All-time low | $0.1165 (Nov 20, 2024) |
| 52-week high | $0.1798 |
| 52-week low | $0.1441 |
| Median price | $0.4723 |
| Average price | $0.4596 |
| Largest weekly change | +41.8% (Jun 25, 2014) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DOXEPIN 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN 50 MG CAPSULE, manufactured by Mylan Pharmaceuticals Inc., is $0.1463 per EA (NDC 00378425010), effective Jun 24, 2026.
How has the price of DOXEPIN 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DOXEPIN 50 MG CAPSULE has declined 41.0%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DOXEPIN 50 MG CAPSULE?
Since Nov 28, 2013, the NADAC for DOXEPIN 50 MG CAPSULE has ranged from a low of $0.1165 (Nov 20, 2024) to a high of $0.9118 (Jan 11, 2017), with a median of $0.4723 per EA.
Are there cheaper alternatives to DOXEPIN 50 MG CAPSULE?
4 NADAC-published products share the same active ingredient, strength, and dosage form as DOXEPIN 50 MG CAPSULE, but none are currently priced below it.
Who manufactures DOXEPIN 50 MG CAPSULE?
DOXEPIN 50 MG CAPSULE (NDC 00378425010) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification